-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
TLR7/8 agonist 4
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2388520-33-8.gif)
| Category | Hepatitis B Virus (HBV) |
| CAS | 2388520-33-8 |
| Description | TLR7/8 agonist 4 is a potent TLR7/8 agonist with anti-cancer activity. |
Product Information
| Synonyms | 3H-Imidazo[4,5-c]quinolin-4-amine, 2-butyl-8-(1-piperazinyl)- |
| IUPAC Name | 2-butyl-8-piperazin-1-yl-3H-imidazo[4,5-c]quinolin-4-amine |
| Molecular Weight | 324.42 |
| Molecular Formula | C18H24N6 |
| Canonical SMILES | CCCCC1=NC2=C(N1)C(=NC3=C2C=C(C=C3)N4CCNCC4)N |
| InChI | InChI=1S/C18H24N6/c1-2-3-4-15-22-16-13-11-12(24-9-7-20-8-10-24)5-6-14(13)21-18(19)17(16)23-15/h5-6,11,20H,2-4,7-10H2,1H3,(H2,19,21)(H,22,23) |
| InChIKey | SPPYNUDMEQYSPQ-UHFFFAOYSA-N |
| Boiling Point | 643.2±50.0°C (Predicted) |
| Purity | ≥98% (HPLC) |
| Density | 1.253±0.06 g/cm3 (Predicted) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 821 |
| Exact Mass | 545.17329015 |
| Target | TLR7, TLR8, HBV 0.10 μM (IC50) |
| XLogP3-AA | 4.1 |
